Tumour control probability after Ruthenium-106 brachytherapy for choroidal melanomas
Sign Up to like & getrecommendations! Published in 2020 at "Acta Oncologica"
DOI: 10.1080/0284186x.2020.1762925
Abstract: Abstract Purpose: Ruthenium-106 (Ru-106) brachytherapy is a common eye-preserving treatment for choroidal melanomas. However, a dose-response model describing the relationship between the actual delivered tumour dose and tumour control has, to the best of our… read more here.
Keywords: dose; control; 106 brachytherapy; ruthenium 106 ... See more keywords
Application of Multimodal and Molecular Imaging Techniques in the Detection of Choroidal Melanomas
Sign Up to like & getrecommendations! Published in 2020 at "Frontiers in Oncology"
DOI: 10.3389/fonc.2020.617868
Abstract: Choroidal melanomas are the most common ocular malignant tumors worldwide. The onset of such tumors is insidious, such that affected patients often have no pain or obvious discomfort during early stages. Notably, enucleation is required… read more here.
Keywords: multimodal molecular; application multimodal; choroidal; choroidal melanomas ... See more keywords